abciximab
Jump to navigation
Jump to search
English[edit]
Etymology[edit]
From (F)ab + -ci- (“cardiovascular”) + -ximab (“chimeric monoclonal antibody”).
Pronunciation[edit]
- (General American) IPA(key): /æbˈsɪk.sɪˌmæb/
Noun[edit]
abciximab (uncountable)
- (pharmacology) A powerful anticlotting drug (trademark ReoPro) that inhibits platelet aggregation by binding to a glycoprotein receptor on human platelets and that consists of the Fab fragment from a chimeric monoclonal antibody prepared from humans and mice.
Translations[edit]
antiplatelet drug
|
References[edit]
- “abciximab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.
Italian[edit]
Etymology[edit]
Unadapted borrowing from English abciximab.
Noun[edit]
abciximab m (invariable)
Portuguese[edit]
Noun[edit]
abciximab m (uncountable)
- (pharmacology) abciximab (antiplatelet drug)
Spanish[edit]
Noun[edit]
abciximab m (uncountable)
Categories:
- English terms interfixed with -ci-
- English terms suffixed with -ximab
- English 4-syllable words
- English terms with IPA pronunciation
- English lemmas
- English nouns
- English uncountable nouns
- en:Pharmaceutical drugs
- Italian terms borrowed from English
- Italian unadapted borrowings from English
- Italian terms derived from English
- Italian lemmas
- Italian nouns
- Italian indeclinable nouns
- Italian countable nouns
- Italian terms spelled with X
- Italian masculine nouns
- Portuguese lemmas
- Portuguese nouns
- Portuguese uncountable nouns
- Portuguese masculine nouns
- pt:Pharmaceutical drugs
- Spanish lemmas
- Spanish nouns
- Spanish uncountable nouns
- Spanish masculine nouns
- es:Pharmaceutical drugs